Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Victory Pharma's MGX-006 enters first of two clinical studies for pivotal development program

June 17, 2008

Dimethyl fumarate shows dual neuroprotective and antiinflammatory effects in multiple sclerosis

June 17, 2008

FDA approves Requip XL for Parkinson's disease

June 16, 2008

Axxonis submits MAA to EMEA for Nenad transdermal patch and subcutaneous infusion

June 16, 2008

Agents for Alzheimer's disease and other neurological disorders disclosed in recent patents

June 16, 2008

Repligen to initiate phase IIb clinical trial of RG-2417 in bipolar disorder

June 16, 2008

Recent patents report novel analgesic agents

June 16, 2008

BioLineRx begins phase IIb BL-1020 trial in schizophrenia

June 16, 2008

Opexa reports positive 2-year data from phase I/II Tovaxin studies

June 13, 2008

Pain and King submit NDA for Remoxy for moderate to severe pain

June 13, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...